Lim Boon Hooi | Health | Best Researcher Award

Best Researcher Award

Lim Boon Hooi

INTI International University, Malaysia

Lim Boon Hooi
Affiliation INTI International University
Country Malaysia
Scopus ID 36846522200
Documents 24
Citations 157
h-index 8
Subject Area Health
Event Global Academic Awards

Lim Boon Hooi is a researcher affiliated with INTI International University in Malaysia whose scholarly profile is associated with the health subject area. The available bibliometric information records 24 documents, 157 citations, and an h-index of 8. These indicators provide a quantitative overview of the researcher’s indexed scholarly output and citation impact. [1] The researcher is considered for recognition under the Best Researcher Award at the Global Academic Awards based on the documented research profile and available scholarly indicators.

Abstract

This academic recognition profile presents the research record of Lim Boon Hooi of INTI International University, Malaysia, in connection with the Best Researcher Award at the Global Academic Awards. The profile summarizes available bibliometric indicators, including 24 indexed documents, 157 citations, and an h-index of 8. These measures are used as descriptive indicators of scholarly productivity and research visibility rather than as standalone measures of research quality. [1]

Keywords

  • Lim Boon Hooi
  • Best Researcher Award
  • Global Academic Awards
  • INTI International University
  • Health research
  • Research impact
  • Bibliometrics
  • Scholarly publications

Introduction

Researcher evaluation commonly considers multiple dimensions of scholarly activity, including publication output, citation performance, research influence, collaboration, and the relevance of published work to a defined academic field. Bibliometric databases such as Scopus provide structured information that can support the assessment of publication and citation records. [1]

Within this context, the profile of Lim Boon Hooi is documented through an identified Scopus author record and a corresponding Google Scholar profile. The available information places the researcher within the health subject area and associates the profile with INTI International University, Malaysia. The Best Researcher Award profile therefore focuses on the documented scholarly record and its measurable research indicators.

Research Profile

Lim Boon Hooi is affiliated with INTI International University in Malaysia and is represented in the supplied scholarly records by Scopus Author ID 36846522200 and Google Scholar identifier NTHbOYIAAAAJ. The available profile data report 24 documents and 157 citations, with an h-index of 8. [1] [2]

Research Contributions

The supplied research profile indicates an established body of indexed scholarly work within the health subject area. With 24 reported documents and 157 citations, the record demonstrates measurable scholarly dissemination and citation activity. The h-index of 8 further indicates that at least eight publications in the reported record have received at least eight citations each, subject to the indexing and profile conditions of the underlying database. [1]

A complete assessment of research contributions should consider the substantive content of individual publications, methodological rigor, originality, collaboration, practical relevance, and contribution to the development of the field in addition to bibliometric indicators. Accordingly, the numerical indicators presented here should be interpreted as components of a broader scholarly assessment.

Publications

The supplied Scopus record reports 24 documents associated with Lim Boon Hooi. [1] The available information provided for this profile does not include a complete publication bibliography or individual article titles. Consequently, no specific publication titles or DOI identifiers are attributed to the researcher here without corresponding bibliographic verification.

For publication-level evaluation, individual records should be reviewed through authoritative indexing or publisher sources. Where applicable, DOI identifiers can provide persistent links to scholarly articles and facilitate verification of publication metadata.

Research Impact

The reported 157 citations provide an indication of the visibility of the researcher’s indexed scholarly output within the citation network represented by the supplied profiles. The h-index of 8 provides an additional measure that combines publication productivity with citation frequency. [1] [2]

Citation-based indicators can be influenced by disciplinary citation practices, publication age, database coverage, collaboration patterns, and other factors. They are therefore most appropriately interpreted alongside qualitative evidence concerning research originality, methodological contribution, societal relevance, and academic influence.

Award Suitability

Based on the supplied profile information, Lim Boon Hooi appears suitable for consideration for the Best Researcher Award at the Global Academic Awards. The documented record includes 24 research documents, 157 citations, and an h-index of 8, together with an institutional affiliation at INTI International University and a subject-area classification in Health. [1]

  • Documented scholarly output through 24 reported documents.
  • Citation activity represented by 157 reported citations.
  • An h-index of 8 within the supplied researcher profile.
  • Academic affiliation with INTI International University, Malaysia.
  • A research profile associated with the Health subject area.
  • Availability of identifiable Scopus and Google Scholar researcher profiles for verification.

Final award decisions should additionally consider the award’s applicable eligibility criteria, the quality and originality of the candidate’s research, publication significance, peer-reviewed contributions, and any supporting evidence submitted during the evaluation process.

Conclusion

Lim Boon Hooi’s supplied academic profile presents a measurable record of scholarly activity in the health field, with 24 reported documents, 157 citations, and an h-index of 8. The combination of indexed research output, citation activity, and institutional affiliation provides a substantive basis for consideration under the Best Researcher Award category. [1] As with all bibliometric evaluations, the quantitative indicators are best interpreted together with qualitative assessment of research quality, originality, relevance, and contribution.

References

  1. Elsevier. (n.d.). Scopus author details: Lim Boon Hooi, Author ID 36846522200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36846522200
  2. Google Scholar. (n.d.). Lim Boon Hooi — Google Scholar profile.
    https://scholar.google.com/citations?user=NTHbOYIAAAAJ&hl=en&oi=sra
  3. Global Academic Awards. (n.d.). Global Academic Awards — Official Award Website.
    https://academicawards.sciencefather.com/
  4. Intrinsic and extrinsic motivation among adolescent ten-pin bowlers in Kuala Lumpur, Malaysia
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4415838/

Fazal Adnan | Antibacterial therapeutics | Best Researcher Award

Assoc. Prof. Dr Fazal Adnan | Antibacterial therapeutics | Best Researcher Award

Head of Department,  Dr.  National University of Sciences and Technology (NUST), Pakistan

Dr. Fazal Adnan is an Associate Professor and Head of the Microbiology & Biotechnology Department at the Atta-ur-Rahman School of Applied Biosciences (ASAB) at NUST University, Islamabad. 🧬 With a Ph.D. in Molecular Microbiology from the University of Giessen, Germany, he has built a distinguished career in molecular microbiology, biotechnology, and antimicrobial therapeutics. 🔬 Leading the Antibacter Research Lab, Dr. Adnan focuses on combating multidrug-resistant (MDR) infections through innovative strategies like phage therapy, CRISPR/Cas9, and synthetic small RNA. 📊 His group investigates bacterial zoonotic potential, resistance profiles, and virulence factors of MDR strains. 📚 He has published over 40 research articles, gained numerous national and international project grants, and established industry collaborations for applied solutions in biotechnology. 🌍 With a dedication to microbial resistance research and cutting-edge education, Dr. Adnan’s work impacts both the academic and industrial fronts of biosciences and microbiology.

Publication Profile

scopus

Education 🎓

Dr. Fazal Adnan completed his Ph.D. in Molecular Microbiology (2011-2015) as a DAAD Fellow at the University of Giessen, Germany, where he studied protein and RNA-based regulation of oxidative stress responses under Prof. Gabriele Klug and Prof. Sylvia Schnell. 📘 His research was funded by the German Research Foundation (DFG). 💡 He earned his M.Phil. in Biotechnology (2007-2009) from GC University Lahore, funded by HEC Pakistan, with a focus on the production and purification of alpha amylase from Bacillus amyloliquefaciens. 🧪 Earlier, he obtained a Bachelor’s in Biotechnology (Hons) from the University of Peshawar, Pakistan, where he studied key areas such as Molecular Biology, Immunology, and Biochemistry. 🧫 These educational experiences have shaped his expertise in biotechnology and microbiology, supporting his innovative research in antibacterial strategies and molecular regulation.

Experience 🌍

🌍 Since July 2015, Dr. Fazal Adnan has been an Associate Professor and Head of the Department of Microbiology & Biotechnology at NUST’s School of Applied Biosciences (ASAB). 💻 He teaches courses in RNA Biology, Phage Therapy, Bioprocess Engineering, and Research Methodology to both undergraduate and postgraduate students. 🔬 He leads the Antibacter Research Lab, working on antibacterial strategies like CRISPR/Cas9, synthetic sRNA, and phage therapy. 👨‍🔬 In 2023, he was a visiting research scientist at Helmholtz AI, Germany, conducting research on whole-genome sequencing data for zoonotic risk assessment of E. coli strains using machine learning. 🤖 Dr. Adnan also serves as an editor for 3Biotech and Frontiers in Microbiology, collaborating globally with institutions like Helmholtz, DAAD, Penn State University, and Bern University.

Awards and Honors 🏆

Dr. Fazal Adnan has earned multiple accolades, including the NUST Star Award for research excellence in 2023 and the Best Teacher Award in 2019. 📜 He has received funding from prestigious agencies such as the Higher Education Commission (HEC) of Pakistan, DAAD, and the Helmholtz Foundation, Germany. 🌐 His expertise in antimicrobial therapeutics has led to various consultancy projects, including a PEPSICO-funded project on soil microbial health. 📚 As an editor for 3Biotech and Frontiers in Microbiology, Dr. Adnan is recognized internationally for his contributions to microbiology and biotechnology. 🎖️ Through national and international partnerships, he advances research on drug-resistant infections, reflecting his commitment to impactful scientific progress in health and biotechnology.

Research Focus 🔬

Dr. Fazal Adnan’s research focuses on antimicrobial therapeutics, specifically tackling multidrug-resistant (MDR) bacterial infections. 💊 His team investigates the zoonotic potential, resistome, and virulence profiling of pathogens like E. coli and studies innovative treatment options such as phage therapy, synthetic small RNA, and antibacterial compounds. 🌏 Using approaches like CRISPR/Cas9, his work targets gene silencing of toxins in bacterial strains, aiming to mitigate infectious diseases in both humans and animals. 🦠 Dr. Adnan leads multiple projects, including a Swiss-funded initiative on phage cocktails against poultry infections, and collaborates internationally with institutions like the Helmholtz Foundation and Bern University. 🧑‍🔬 With over 40 published research articles, Dr. Adnan’s research addresses global health challenges in antibiotic resistance, contributing to the fields of microbiology and one health science.

Publication Top Notes

“Effects of imidazole derivatives on cellular proliferation and apoptosis in myeloid leukemia”
Authors: Nadeem, B.B., Bibi, A., Khan, M., Ahmad, Z., Khan, D.
Journal: BMC Cancer, 2024, 24(1), 1200.
Summary: This study explores the impact of imidazole derivatives on cell growth and apoptosis in myeloid leukemia cells, with implications for potential therapies.

“Synthesis, evaluation, and in silico studies of imidazolium and pyridinium-based ionic liquids with Dioctyl succinamic acid anion for enhanced antibacterial applications”
Authors: Hadeesa Kazmi, S., Arshad, A., Hafeez, S., Adil Mansoor, M., Iqbal, M.
Journal: Journal of Molecular Liquids, 2024, 401, 124714.
Summary: This research develops ionic liquids with potential antibacterial properties, analyzing both their synthesis and computational attributes.

“Mycorrhizosphere bacteria inhibit greenhouse gas emissions from microplastics contaminated soil by regulating soil enzyme activities and microbial community structure”
Authors: Khan, Z., Shah, T., Haider, G., Bhatti, M.F., Ahmad, P.
Journal: Journal of Environmental Management, 2024, 356, 120673.
Summary: The study shows that mycorrhizosphere bacteria can mitigate greenhouse gas emissions in soils contaminated by microplastics.

“Biomineralization and corrosion inhibition of steel in simulated bio-inspired self-healing concrete”
Authors: Kanwal, M., Adnan, F., Khushnood, R.A., Wattoo, A.G., Rasheed, S.
Journal: Journal of Building Engineering, 2024, 82, 108224.
Summary: This article investigates biomineralization techniques to improve steel corrosion resistance within self-healing concrete structures.

“Synthesis of non-cytotoxic Co3O4 nanocatalysts for thermocatalytic methane decomposition by resource recovery”
Authors: Mughal, S., Sehole, H.A.H., Mumtaz, A., Zhao, H., Janjua, H.A.
Journal: Biomass Conversion and Biorefinery, 2024, 14(3), pp. 3927–3945.
Summary: This study synthesizes Co3O4 nanocatalysts for sustainable methane decomposition, highlighting their non-toxic nature.

“Designing of fragment based inhibitors with improved activity against E. coli AmpC β-lactamase compared to the conventional antibiotics”
Authors: Hafeez, S., Zafar Paracha, R., Adnan, F.
Journal: Saudi Journal of Biological Sciences, 2024, 31(1), 103884.
Summary: This research focuses on creating inhibitors that outperform traditional antibiotics against E. coli AmpC β-lactamase.

“Combating Cariogenic Streptococcus mutans Biofilm Formation and Disruption with Coumaric Acid on Dentin Surface”
Authors: Ahmad, S.S., Siddiqui, M.F., Maqbool, F., Alsowayeh, N., Rahman, Z.
Journal: Molecules, 2024, 29(2), 397.
Summary: This open-access article demonstrates how Coumaric Acid can prevent biofilm formation on dentin by Streptococcus mutans, a major cause of dental caries.

“Biochar alleviated the toxic effects of PVC microplastic in a soil-plant system by upregulating soil enzyme activities and microbial abundance”
Authors: Khalid, A.R., Shah, T., Asad, M., Kammann, C.I., Haider, G.
Journal: Environmental Pollution, 2023, 332, 121810.
Summary: The study shows biochar’s ability to reduce PVC microplastic toxicity in soil-plant systems by enhancing microbial communities.

“High resistance of fluoroquinolone and macrolide reported in avian pathogenic Escherichia coli isolates from the humid subtropical regions of Pakistan”
Authors: Jalil, A., Masood, S., Ain, Q., Dudley, E.G., Adnan, F.
Journal: Journal of Global Antimicrobial Resistance, 2023, 33, pp. 5–17.
Summary: The research reports significant antibiotic resistance in avian pathogenic E. coli strains from Pakistan, particularly to fluoroquinolones and macrolides.

“Functional annotation and comparative analysis of four Botrytis cinerea mitogenomes reported from Punjab, Pakistan”
Authors: Fatma, T., Ahmed Khan, H., Ahmed, A., Virk, N., Faraz Bhatti, M.
Journal: Saudi Journal of Biological Sciences, 2023, 30(4), 103605.
Summary: This open-access article provides insights into the genetic diversity of Botrytis cinerea in Pakistan, a fungal pathogen affecting various crops.

Conclusion

Dr. Fazal Adnan is a compelling candidate for the Best Researcher Award due to his contributions to fighting antibiotic resistance through innovative approaches like phage therapy and CRISPR applications. His academic achievements, along with his commitment to teaching and his active research collaborations, showcase a strong alignment with the award’s criteria. With targeted advancements in patent acquisition and international partnerships, Dr. Adnan’s profile could further solidify his reputation in antibacterial therapeutics and global health.